| 1 |
35526523 | M1 Macrophages Increase Endothelial Permeability and Enhance p38 Phosphorylation via PPAR-γ/CXCL13-CXCR5 in Sepsis. | 2022 May 6 |
1 |
| 2 |
32025515 | Altered Expression of Long Noncoding and Messenger RNAs in Diabetic Nephropathy following Treatment with Rosiglitazone. | 2020 |
1 |
| 3 |
31160894 | Rosiglitazone promotes ENaC-mediated alveolar fluid clearance in acute lung injury through the PPARγ/SGK1 signaling pathway. | 2019 |
1 |
| 4 |
31263138 | Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model. | 2019 Jul 1 |
1 |
| 5 |
31493866 | Inhibition of perivascular mast cell activation is involved in the atheroprotective effect of rosiglitazone in apolipoprotein E-deficient mice. | 2019 Nov 5 |
2 |
| 6 |
31561855 | Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner. | 2019 Nov 19 |
3 |
| 7 |
31871424 | Adipose-Derived Stromal Cells Attenuate Adipose Inflammation in Obesity through Adipocyte Browning and Polarization of M2 Macrophages. | 2019 |
1 |
| 8 |
28024724 | A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model. | 2017 Jan |
1 |
| 9 |
28344789 | A PPAR-gamma agonist protects from radiation-induced intestinal toxicity. | 2017 Mar |
1 |
| 10 |
26618986 | A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS. | 2016 Apr |
1 |
| 11 |
26773728 | Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation. | 2016 Mar 5 |
2 |
| 12 |
27208887 | Rosiglitazone-mediated dendritic cells ameliorate collagen-induced arthritis in mice. | 2016 Sep 1 |
1 |
| 13 |
27545964 | Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice. | 2016 Aug 22 |
1 |
| 14 |
25134730 | Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. | 2014 Nov |
1 |
| 15 |
23212557 | Inhibition of CTRP9, a novel and cardiac-abundantly expressed cell survival molecule, by TNFα-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice. | 2013 Jan |
1 |
| 16 |
22778214 | TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. | 2012 Sep |
1 |
| 17 |
21839812 | Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model. | 2011 Oct 27 |
3 |
| 18 |
19481767 | Adiponectin deficiency promotes the production of inflammatory mediators while severely exacerbating hepatic injury in mice with polymicrobial sepsis. | 2010 Jun 15 |
1 |
| 19 |
19953004 | Thiazolidinediones inhibit TNF-alpha-mediated osteoclast differentiation of RAW264.7 macrophages and mouse bone marrow cells through downregulation of NFATc1. | 2010 Jun |
1 |
| 20 |
20877467 | PPARγ ligands switched high fat diet-induced macrophage M2b polarization toward M2a thereby improving intestinal Candida elimination. | 2010 Sep 20 |
1 |
| 21 |
19219422 | Involvement of TNF-alpha in abnormal adipocyte and muscle sortilin expression in obese mice and humans. | 2009 May |
1 |
| 22 |
19221061 | Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription. | 2009 May |
1 |
| 23 |
19324019 | IGFBP-3, hypoxia and TNF-alpha inhibit adiponectin transcription. | 2009 May 15 |
2 |
| 24 |
18473419 | Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. | 2008 May 14 |
2 |
| 25 |
18846339 | Significance of rosiglitazone inhibiting TLR4 expression in partial hepatic ischemia/reperfusion of mice. | 2008 Oct |
1 |
| 26 |
17416798 | Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway. | 2007 Jul |
1 |
| 27 |
16539667 | Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. | 2006 Apr |
1 |
| 28 |
16728429 | Rosiglitazone ameliorates cisplatin-induced renal injury in mice. | 2006 Aug |
2 |
| 29 |
15671204 | Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy. | 2005 May |
1 |
| 30 |
15735429 | The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. | 2005 Mar |
1 |
| 31 |
15797891 | Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model. | 2005 Jun |
3 |
| 32 |
15865214 | Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors. | 2005 |
1 |
| 33 |
15932692 | [Rosiglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice]. | 2005 May |
2 |
| 34 |
17491689 | Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes. | 2005 Fall |
1 |
| 35 |
12734379 | Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response. | 2003 May 15 |
1 |
| 36 |
12144946 | PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice. | 2002 Jul 19 |
1 |